注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Scisparc Ltd(原名:Therapix Biosciences Ltd)是一家以色列制药公司。该公司致力于建立和增强基于大麻素药物的技术和资产。该公司正在进行基于大麻素(Dronabinol)再利用的药物开发项目:THX-110用于治疗抽动秽语综合征(TS)、阻塞性睡眠呼吸暂停(OSA)和疼痛;THX-130用于治疗轻度认知障碍(MCI)和创伤性脑损伤(TBI);THX-150用于治疗传染病;以及THX-160用于治疗疼痛。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Avi Weizman | - | 2016 | Member of Scientific Advisory Board |
Kirsten Müller-Vahl | - | 2016 | Member of Scientific Advisory Board |
Joseph Tam | - | - | Member of Scientific Advisory Board |
Daniele Piomelli | - | - | Member of Scientific Advisory Board |
Mellar P. Davis | - | - | Member of Scientific Advisory Board |
Michael H. Bloch | - | 2016 | Member of Scientific Advisory Board |
Alon Dayan | 46 | 2021 | Independent Director |
Amitai Weiss | 62 | 2020 | Chairman of the Board |
Moshe Revach | 47 | 2020 | Independent Director |
Itschak Shrem | 77 | 2020 | President & Director |
Michael Davidson | 74 | 2016 | Member of Scientific Advisory Board |
Elon Eisenberg | - | - | Member of Scientific Advisory Board |
Lior Vider | 48 | 2020 | Independent Director |
Liat Sidi | 49 | 2020 | Independent Director |
Saoirse O'Sullivan | - | - | Member of Scientific Advisory Board |
Amnon Ben Shay | 60 | 2021 | Independent Director |
Avi Schroeder | - | - | Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核